Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc.
Swiss Cancer Institute
Mayo Clinic
Stanford University
National Cancer Institute (NCI)
City of Hope Medical Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NYU Langone Health
Case Comprehensive Cancer Center